JPMorgan Chase & Co. (JPM) — Q2 2026 Earnings Preview

Company

JPMorgan Chase & Co.

Earnings Date

July 15, 2026

Ticker

JPM

Reporting Period

Q2 2026

Sector

Large-Cap U.S. Banks

Prepared Date

July 13, 2026

Sector ETF

KBE (SPDR S&P Bank ETF)

Last Close

$334.53 (July 13, 2026)

1. Earnings Preview

Key Takeaway: The setup favors another beat — consensus is a manageable bar after only modest upward revision post-Q1, and JPM enters Q2 with markets and IB tracking in line to slightly ahead of estimates; the single biggest swing factor is whether the record-level trading volumes of Q1 can sustain into Q2 or mean-revert sharply.

JPMorgan heads into Q2 2026 earnings with consensus expecting diluted operating EPS of ~$5.56 and revenue of ~$50.9B — a bar that looks achievable but not easy given the exceptionally high Q1 2026 comp ($5.94 EPS, $49.8B revenue). Management held full-year NII ex-Markets guidance at ~$95B and expense guidance at ~$105B on the Q1 call (subsequently nudged to ~$106B at the Bernstein conference in late May, citing higher comp tied to strong fees and trading volumes), signaling confidence in the underlying earnings engine without over-promising on the volatile markets line. Estimate revisions have been modestly positive since Q1 earnings — the April 21 consensus for Q2 EPS stood at ~$5.41 vs. the current ~$5.56, a ~2.8% upward drift — suggesting the Street has partially priced in continued strength but has not fully extrapolated Q1's record markets performance. The stock has rallied ~7% from the April 14 earnings close of $311 to ~$335 today, outperforming the KBE (+8.6%) and broadly in line with the SPY (+7.8%), and now trades at roughly 14–15x forward earnings — a premium to historical norms that leaves limited room for a miss. The key wildcard is the sustainability of Markets revenue: FICC came in at $7.1B in Q1 (a record), and consensus for Q2 is ~$6.2B — a meaningful step-down that management has not explicitly guided against, but which peers (BAC, WFC, C) have broadly corroborated with constructive commentary on capital markets activity through mid-Q2.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus is a moderate bar — the revenue and EPS estimates embed a meaningful step-down from Q1’s record quarter, but NII ex-Markets is the more predictable anchor while Markets revenue is the bigger swing factor. A beat on credit quality (card NCO rate) could be the positive surprise.

Table 1 — Q2 2026 Current Quarter Snapshot (All Key KPIs)

KPI

Q1 2026 Actual

Q2 2025 Actual (Prior Year)

Q2 2026 Consensus Est.

YoY Change

Guidance

Cons. vs. Guidance

Total Revenue, Net of Interest Expense

$49.8B

$44.9B

$50.9B

+13.4%

FY ~$198B (implied)

In line

NII ex-Markets (FTE)

$23.3B

$22.8B

$23.7B

+4.1%

FY ~$95B

+0.7% above run-rate

Investment Banking Fees

$2.86B

$2.50B

$2.85B

+14.0%

Pipelines healthy; Middle East risk flagged

N/A (no explicit IB guidance)

FICC Markets Revenue

$7.1B

$5.7B

$6.2B

+9.1%

No explicit quarterly guidance

N/A

Equities Markets Revenue

$4.5B

$3.2B

$4.0B

+23.2%

No explicit quarterly guidance

N/A

EPS — Diluted Operating

$5.94

$4.96

$5.56

+12.1%

No explicit EPS guidance

N/A

ROTCE

22.4%

21.1%

22.4%

+130 bps

FY ~21.0% (implied)

Slightly above FY run-rate

Card Net Charge-Off Rate

3.47%

3.40%

3.50%

+10 bps

FY ~3.4%

+10 bps above guidance midpoint

CET1 Ratio (Fully Phased-In)

14.1%

15.1%

14.2%

-90 bps

Managed above regulatory minimums; SCB 2.5%

N/A (no explicit target)

Total Noninterest Expenses

$26.9B

$23.8B

$26.5B

+11.4%

FY ~$106B (updated May 2026)

Slightly below FY run-rate

Provision for Credit Losses

$2.5B

$2.8B

$3.1B

+10.7%

No explicit quarterly guidance

N/A

Sources: Visible Alpha Consensus and Actuals Data; JPM Q1 2026 Earnings Call (April 14, 2026); Bernstein Strategic Decisions Conference (May 2026).

3. Guidance & Commentary Evolution

Key Takeaway: Management’s tone has shifted modestly more cautious on the consumer since Q1 earnings — flagging an emerging subset of customers where wage growth is no longer keeping pace with inflation — while remaining constructive on capital markets and NII. The expense guide nudge to ~$106B is a minor negative but reflects revenue strength, not cost creep.

Topic

Q1 2026 Earnings Call Guidance / Tone (April 14, 2026)

Revised / Updated Guidance (Post-Q1)

Direction

NII ex-Markets (FY 2026)

~$95B; unchanged despite rate path shift; EAR of $1.8B had minimal full-year impact

Unchanged at ~$95B as of latest commentary

→ Unchanged

Total NII (FY 2026)

~$103B; Markets NII revised down to ~$8B due to rates, offset in NIR

Unchanged

→ Unchanged

Adjusted Expenses (FY 2026)

~$105B; described as an “outcome of business results,” not a promise; upside risk if volumes stay elevated

Nudged to ~$106B at Bernstein conference (May 2026), citing higher comp tied to stronger fees and trading volumes

↑ Slight increase (revenue-driven)

Card Net Charge-Off Rate (FY 2026)

~3.4%; tracking at low end of guided range; consumer resilient

Tracking at low end of range as of June 2026; management flagging emerging (small) subset of consumers where wage growth no longer keeping pace with inflation

→ Unchanged but tone slightly more watchful

Card Loan Growth (FY 2026)

~6% or slightly more; unchanged from Company Update

Unchanged

→ Unchanged

Consumer Deposit Growth

Low-to-mid single digits; Q1 up 2% YoY/QoQ aided by tax refunds

Deposit growth inflection now expected in H2 2026 (pushed from H2 2025); lower personal savings rates and equity market flows cited

↓ Timing pushed out

Investment Banking / Pipelines

Pipelines “resilient, maybe surprisingly resilient”; Middle East risk flagged for deal timing; Q1 IB fees +28% YoY partly from accelerated M&A closures

Markets and IB revenues tracking in line to slightly ahead of estimates through mid-Q2 per management commentary

↑ Constructive

Capital Return

Patient deployment; Apple Card integration ongoing; buybacks secondary to organic growth

Post-CCAR (June 24, 2026): $50B buyback authorized (effective July 1); quarterly dividend raised 10% to $1.65/share (pending board approval)

↑ Significantly more aggressive

Consumer Macro Tone

Consumer resilient; credit quality better than expected; real wages under pressure in April 2026 for first time in a while

Watchful but not alarmed; cash buffers normalizing; labor demand softening for a small but growing subset of customers

↓ Slightly more cautious

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimate revisions have been modestly positive since Q1 earnings, with Q2 2026 Operating EPS consensus rising ~2.8% from $5.41 (April 21 snapshot) to $5.56 currently — suggesting the Street has partially but not fully priced in continued markets strength. The NII ex-Markets estimate is tracking slightly above the implied quarterly run-rate of the $95B full-year guide, which is a mild positive.

KPI

Guidance / Management View

Consensus at Q1 Earnings (Apr 21, 2026)

Current Consensus (Jul 13, 2026)

Revision Direction

Gap vs. Guidance

Operating EPS (Q2 2026)

No explicit quarterly EPS guidance

$5.41

$5.56

+2.8% ↑

N/A

Total Revenue (Q2 2026)

FY ~$198B implied; no Q2 explicit guide

$48.3B

$50.9B

+5.4% ↑

In line with FY run-rate

NII ex-Markets (Q2 2026)

FY ~$95B (~$23.75B/quarter implied)

$23.6B

$23.7B

+0.5% ↑

+0.7% above implied quarterly run-rate

IB Fees (Q2 2026)

Pipelines healthy; no explicit quarterly guide

$2.81B

$2.85B

+1.4% ↑

N/A

Total Expenses (Q2 2026)

FY ~$106B (~$26.5B/quarter implied)

$26.2B

$26.5B

+1.2% ↑ (slight creep)

In line with updated FY guide

Sources: Visible Alpha Consensus and Actuals Data (April 21, 2026 as-of snapshot and current); JPM Q1 2026 Earnings Call; Bernstein Strategic Decisions Conference (May 2026).

5. Stock Performance

Key Takeaway: JPM has rallied ~7.5% since Q1 earnings (April 14 close: $311.12 → July 13 close: $334.53), broadly in line with the SPY (+7.9%) and slightly lagging the KBE (+8.6%), suggesting the stock has not dramatically re-rated on a relative basis despite the exceptional Q1 beat — the premium multiple (~14–15x forward P/E) leaves limited margin for error heading into Q2.

Metric

JPM

KBE

SPY

Close at Q1 Earnings (Apr 14, 2026)

$311.12

$63.35

$694.46

Close on July 13, 2026

$334.53

$68.82

$749.17

Return Since Q1 Earnings

+7.5%

+8.6%

+7.9%

52-Week Range (approx.)

~$295–$340

N/A

N/A

Post-CCAR Rally (Jun 24 close)

$333.45 (+7.2% from Apr 14)

$67.49

$733.24

Trough Since Q1 Earnings

$295.70 (May 19, 2026)

$61.68 (May 15)

$733.73 (May 19)

Note: JPM sold off from ~$315 to ~$296 between late April and mid-May 2026 (a ~6% drawdown), likely reflecting broader macro concerns and the stock’s premium valuation. The stock recovered sharply in June, aided by the CCAR results (June 24) which triggered the $50B buyback authorization and 10% dividend hike announcement. The stock is now trading near its post-Q1 highs, entering Q2 earnings with a full valuation. Source: Stock Price Data.

Indexed Price Performance: JPM vs. KBE vs. SPY (Since April 14, 2026 Q1 Earnings Date)

Date

JPM (Indexed)

KBE (Indexed)

SPY (Indexed)

Apr 14, 2026 (Base = 100)

100.0

100.0

100.0

Apr 30, 2026

100.7

101.3

103.5

May 15, 2026

95.7

97.4

106.5

May 29, 2026

96.2

100.2

108.9

Jun 12, 2026

103.1

105.6

106.8

Jun 24, 2026 (CCAR)

107.2

106.5

105.6

Jul 7, 2026

109.0

108.5

107.7

Jul 13, 2026 (Latest)

107.5

108.6

107.9

Source: Stock Price Data. Indexed to 100 at April 14, 2026 close. Note: JPM underperformed the KBE and SPY through mid-May as the stock gave back some of its pre-earnings rally, then recovered sharply in June on CCAR-driven capital return announcements.

6. Material News & Developments (Since Q1 2026 Earnings)

Key Takeaway: The most significant post-Q1 development is the CCAR-driven $50B buyback authorization and 10% dividend hike — a major capital return signal that reinforces the fortress balance sheet narrative. The Basel III endgame and GSIB surcharge proposals remain a medium-term overhang but are not expected to affect Q2 results.

7. Peer Commentaries — Last 60 Days (Read-Through Analysis)

Key Takeaway: Peer commentary from BAC, WFC, C, and GS across the Bernstein and Morgan Stanley U.S. Financials conferences (May–June 2026) is broadly constructive for JPM’s Q2 setup: NII is tracking at or above guidance across the group, IB pipelines are described as full and active, consumer credit quality remains solid, and capital markets activity is strong. The one consistent caution is macro uncertainty (Middle East, tariff drag) that could affect deal timing.

Bank of America (BAC) — Bernstein Conference (May 27, 2026) & MS Financials Conference (June 9, 2026)

Read-Through Relevance: HIGH. BAC is JPM’s closest large-cap peer across consumer banking, NII sensitivity, and capital markets.

Wells Fargo (WFC) — MS Financials Conference (June 9, 2026) & Bernstein Conference (May 27, 2026)

Read-Through Relevance: MEDIUM-HIGH. WFC is a key read-through on consumer banking, NII, and credit quality, though less relevant on capital markets.

Citigroup (C) — Investor Day (May 7, 2026) & MS Financials Conference (June 9, 2026)

Read-Through Relevance: MEDIUM. Citi is most relevant as a read-through on institutional/wholesale banking, capital markets, and global macro sentiment.

Goldman Sachs (GS) — Bernstein Conference (May 28, 2026) & CCAR Statement (June 24, 2026)

Read-Through Relevance: HIGH for capital markets (FICC, equities, IB). GS is the most direct read-through for JPM’s CIB performance.

Peer Read-Through Summary Table

Peer

NII / Deposits

Consumer Credit

IB / Capital Markets

Macro Tone

Overall JPM Read-Through

BAC

↑ Positive (guidance raised to 6–8%)

↑ Positive (credit quality “great”)

↑ Positive (pipelines full, IB “very strong”)

Constructive; GDP ~2.2%

POSITIVE

WFC

→ Neutral/Positive (stable NII)

→ Neutral (stable, no deterioration)

→ Neutral (less capital markets exposure)

Stable; efficiency focus

NEUTRAL/POSITIVE

C

→ Neutral (transformation ongoing)

→ Neutral (no material issues)

↑ Positive (institutional client activity solid)

Cautious on geopolitics

NEUTRAL/POSITIVE

GS

N/A (no NII focus)

N/A

↑ Positive (strong markets, M&A, underwriting)

Constructive; capital return confidence

POSITIVE

Sources: BAC Bernstein Strategic Decisions Conference (May 27, 2026); BAC Morgan Stanley U.S. Financials Conference (June 9, 2026); WFC Morgan Stanley U.S. Financials Conference (June 9, 2026); WFC Bernstein Strategic Decisions Conference (May 27, 2026); C Investor Day (May 7, 2026); C Morgan Stanley U.S. Financials Conference (June 9, 2026); GS Bernstein Strategic Decisions Conference (May 28, 2026); GS CCAR Statement (June 24, 2026); MS CCAR Statement (June 24, 2026).

8. Insider Transaction Activity

Key Takeaway: All insider transactions since Q1 earnings are sales, and all are under pre-established 10b5-1 trading plans — indicating these are scheduled, non-discretionary dispositions rather than signals of negative conviction. The most notable is CEO Jamie Dimon’s sale of 130,488 shares on April 15, 2026, consistent with his previously disclosed plan. No open-market purchases by insiders have been recorded in the period.

Date

Insider

Role

Transaction

Shares

10b5-1 Plan?

Shares Owned After

Apr 15, 2026

James Dimon

Chairman & CEO

Sale

130,488

Yes

1,680,625

Apr 15, 2026

Ashley Bacon

Chief Risk Officer

Sale

7,558

Yes

252,855

Apr 15, 2026

Jeremy Barnum

Chief Financial Officer

Sale

5,611

Yes

35,460

Apr 15, 2026

Lori A. Beer

Chief Information Officer

Sale

3,166

Yes

69,948

Apr 15, 2026

Marianne Lake

CEO, CCB

Sale (via GRATs)

6,427

Yes

130,872

Apr 15, 2026

Douglas B. Petno

Co-CEO, CIB

Sale

5,660

Yes

381,807

Apr 15, 2026

Jennifer Piepszak

Chief Operating Officer

Sale

9,136

Yes

90,001

May 5, 2026

Ashley Bacon

Chief Risk Officer

Sale

4,070

Yes

248,785

May 5, 2026

Jeremy Barnum

Chief Financial Officer

Sale

3,022

Yes

32,438

May 5, 2026

Jennifer Piepszak

Chief Operating Officer

Sale

4,919

Yes

85,082

May 15, 2026

Lori A. Beer

Chief Information Officer

Sale

3,165

Yes

66,783

May 15, 2026

Marianne Lake

CEO, CCB

Sale (via GRATs)

6,427

Yes

76,402

May 15, 2026

Douglas B. Petno

Co-CEO, CIB

Sale

5,659

Yes

224,619

May 20, 2026

Stacey Friedman

General Counsel

Sale

5,468

Yes

46,428

Jun 22, 2026

Stacey Friedman

General Counsel

Sale

5,467

Yes

40,961

Note: All transactions are dispositions (sales) under pre-established 10b5-1 trading plans. No open-market purchases recorded in the period. The April 15 cluster of sales across the C-suite is consistent with post-earnings window opening and scheduled plan execution. Dimon’s 130,488-share sale is the largest by volume but represents a small fraction of his 1.68M+ share position. Source: SEC Form 4 Filings.